Metabolic Bone Disease: What's New in 2017?
If you attended the Metabolic Bone Disease: What's New in 2017? session held Friday, May 5, 2017 at the AACE Annual Meeting in Austin, TX, please proceed to attempt this assessment for ABIM Maintenance of Certification (MOC) credit. To begin, select the red 'Take Course' tab. You must be logged in to access the assessment.
- AACE Members: login with the same username/password used for the AACE website.
- Non-AACE Members: login using the non-member portal if you have an existing non-member account OR create an account if you are new to the AACE Education website.
Once logged in, you will be prompted to enter the access code you received onsite (found on page 7 of the Schedule-at-a-Glance). If you need assistance, please contact email@example.com.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website.
Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
- Discuss the latest recommendations for the diagnosis and treatment of postmenopausal osteoporosis
- Review the 2016 AACE Postmenopausal Osteoporosis Treatment Algorithm
- Discuss controversies in the long term management of postmenopausal osteoporosis
- Understand the cellular defects in bone from hyperglycemia
- Define the clinical manifestations of diabetic osteopathy
- Delineate the treatment options for diabetic bone disease
- Apply the AACE guidelines to prevention of osteoporosis
- Review approach to those that can benefit the most from pharmacological therapy
- Differentiate treatment options to individualize therapy approach
- Summarize the effectiveness and limitations of current treatments
- Interpret the results of studies evaluating the skeletal effects of abaloparatide
- Explain the treatment effects of inhibiting sclerostin activity
- Review the evidence behind the potential link between vitamin D and type 2 diabetes
- Appreciate the potential pitfalls in interpreting the available evidence
- Review current recommendations and review ongoing studies on vitamin D and diabetes
Pauline Camacho, MD; Clifford Rosen, MD; Steven Petak, MD; Michael R. McClung, MD; Anastassios G. Pittas, MD
- 2.75 MOC